AJP - Endo Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (March 25, 2008). doi:10.1152/ajpendo.00529.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/6/E1070    most recent
00529.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sell, H.
Right arrow Articles by Eckel, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sell, H.
Right arrow Articles by Eckel, J.
Submitted on August 15, 2007
Accepted on March 15, 2008

Skeletal muscle insulin resistance induced by adipocyte-conditioned medium: underlying mechanisms and reversibility

Henrike Sell1, Kristin Eckardt1, Annika Taube1, Daniel Tews2, Mihaela Gurgui3, Gerhild van Echten-Deckert4, and Jurgen Eckel1*

1 Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Dusseldorf, Germany
2 Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Duesseldorf, Germany
3 2. Kekule-Institute for Organic Chemistry und Biochemistry, University of Bonn, Bonn, Germany
4 Kekule-Institute for Organic Chemistry und Biochemistry, University of Bonn, Bonn, Germany

* To whom correspondence should be addressed. E-mail: eckel{at}uni-duesseldorf.de.

Insulin resistance in skeletal muscle is an early event in the development of diabetes with obesity being one major contributing factor. In vitro, conditioned medium (CM) from differentiated human adipocytes impairs insulin signaling in skeletal muscle cells but it is not known if insulin resistance is reversible and which mechanisms underlie this process. CM induced insulin resistance in human myotubes at the level of insulin-stimulated Akt and GSK3 phosphorylation. In Insulin-resistant skeletal muscle cells exhibit enhanced production of reactive oxygen species and ceramide as well as a downregulation of myogenic transcription factors such as myogenin and myoD. However, insulin resistance was not paralleled by increased apopotosis. Regeneration of myotubes for 24 or 48 h after induction of insulin resistance restored normal insulin signaling. However, the expression level of myogenin could not be reestablished. In addition to decreasing myogenin expression, CM also decreased the release of IL-6 and IL-8, and increased monocyte chemotactic protein-1 (MCP-1) secretion from skeletal muscle cells. While regeneration of myotubes reestablished normal secretion of IL-6 the release of IL-8 and MCP-1 remained impaired after withdrawal of CM. In conclusion, our data show that insulin resistance in myotubes is only partially reversible. While some characteristic features of insulin resistant myotubes normalize in parallel to insulin signaling after withdrawal of CM, others such as IL-8 and MCP-1 secretion and myogenin expression remain impaired over a longer period. Thus, we propose that the induction of insulin resistance may cause irreversible changes of protein expression and secretion in skeletal muscle cells.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Q. G. Zhou, M. Zhou, F. F. Hou, and X. Peng
Asymmetrical dimethylarginine triggers lipolysis and inflammatory response via induction of endoplasmic reticulum stress in cultured adipocytes
Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E869 - E878.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.